Pulmonary fibrosis is a condition that causes scar tissue to form in the lungs. It can be caused by environmental factors, diseases like lupus or it can occur spontaneously for reasons that are completely unknown. Individuals who are suffering from pulmonary fibrosis experience decreased lung function. This results in difficulty breathing as well as severe fatigue. Advanced cases can result in hypoxia where an insufficient amount of oxygen is being passed through the pulmonary artery. The most common treatments for this condition are medications and eventually a lung transplant if the scarring becomes severe enough. One common fibrosis treatment is the use of drugs that suppress the immune system. The formation of scar tissue in the lungs in some individuals is connected to an overreaction of the immune system. The body then attacks the tissue in the lining of the lungs and destroys the area. The result is that the body heals the damage with a scar. These scars are not able to be treated surgically. Immune suppressing medications can sometimes stop the body from attacking its own lung tissue. This will slow the development of scar tissue. Patients who are taking immune suppression medications, however, have a lowered immune response to other factors. This can result in other serious illnesses that can be contracted from the environment. Individuals who do not respond to immune suppressing medications can sometimes be given a corticosteroid. This can reduce symptoms over time. Corticosteroids are not effective for everyone and the large majority of patients show no response to the drug. Patients who are unresponsive to medications are often given oxygen therapy. This is not a direct fibrosis treatment but instead is intended to make living with the condition easier. Oxygen therapy involves administering oxygen through a mask to the patient to increase the amount of oxygen that is in the blood. This helps to mitigate the effects of hypoxia and can give a patient much more energy for a short period of time. The combination of serrapeptase and nattokinase can be used as a pulmonary fibrosis treatment. These are enzymes that serve two different functions. Serrapeptase acts as an anti-inflammatory medication and nattokinase can help to reduce clotting. Both have the ability to bind with fibrin that has developed in the scar tissue in the lungs. This effectively dissolves scar tissue over the course of several months. The result is that the lungs will slowly being to heal as the scar tissue is removed. The blood-thinning properties of nattokinase can also help to increase the functioning of the lungs so that more oxygen is available in the body. For more information about fibrosis treatment and good tips about where to find fibrosis treatment, visit our website.
Related Articles -
fibrosis, treatment,
|